Determination of free and total cortisol in plasma and urine by liquid chromatography-tandem mass spectrometry

Therapeutic Drug Monitoring

Volumn 29, Issue 2, 2007, Pages 215-224

  Huang, Weili ^a   Kalhorn, Thomas F ^a   Baillie, Mark ^a   Shen, Danny D ^a   Thummel, Kenneth E ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Cortisol; Mass spectrometry; Multiple reactant monitoring; Plasma protein binding; Renal cortisol clearance

Indexed keywords

ACETIC ACID ETHYL ESTER; AMMONIUM CHLORIDE; HYDROCORTISONE; METHANOL; METHYLPREDNISOLONE;

ADRENAL FUNCTION; ADULT; AQUEOUS SOLUTION; ARTICLE; CALIBRATION; CHEMICAL STRUCTURE; CONTROLLED STUDY; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; LIQUID CHROMATOGRAPHY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BINDING; QUALITY CONTROL; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; TANDEM MASS SPECTROMETRY;

ADOLESCENT; ADULT; BLOOD PROTEINS; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; HYDROCORTISONE; MALE; METHYLPREDNISOLONE; MIDDLE AGED; PROTEIN BINDING; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY;

EID: 34248179035     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/FTD.0b013e31803d14c0     Document Type: Article

References (28)

1. Majid O, Akhlaghi F, Lee T, et al. Simultaneous determination of plasma prednisolone, prednisone, and cortisol levels by high-performance liquid chromatography. Ther Drug Monit. 2001;23:163-168.
2. Lebrun-Vignes B, Archer VC, Diquet B, et al. Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and cortisol secretion in healthy subjects. Br J Clin Pharmacol. 2001;51:443-450.
3. Lentjes EG, Romijn FH. Temperature-dependent cortisol distribution among the blood compartments in man. J Clin Endocrinol Metab. 1999;84:682-687.
4. Hamrahian AH, Oseni TS, Arafah BM. Measurements of serum free cortisol in critically ill patients. N Engl J Med. 2004;350:1629-1638.
5. Coolens JL, Van Baelen H, Heyns W. Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin. J Steroid Biochem. 1987;26:197-202.
6. Stolk RP, Lamberts SW, de Jong FH, et al. Gender differences in the associations between cortisol and insulin in healthy subjects. J Endocrinol. 1996;149:313-318.
7. Lentjes EG, Romijn F, Maassen RJ, et al. Free cortisol in serum assayed by temperature-controlled ultrafiltration before fluorescence polarization immunoassay. Clin Chem. 1993;39:2518-2521.
8. Lentjes EG, Romijn FP, Moolenaar AJ. Isotope effect in the binding of tritium and 14C-labelled cortisol to corticosteroid-binding-globulin in serum. J Steroid Biochem Mol Biol. 1997;60:255-260.
9. Torpy DJ, Bachmann AW, Grice JE, et al. Familial corticosteroid-binding globulin deficiency due to a novel null mutation: association with fatigue and relative hypotension. J Clin Endocrinol Metab. 2001;86:3692-3700.
10. Shah VP, Midha KK, Findlay JW, et al. Bioanalytical method validation: a revisit with a decade of progress. Pharm Res. 2000;17:1551-1557.
11. Rowland M, Tozer TN. Clinical Pharmacokinetics: Concepts and Applications. Third edition. Baltimore: Williams & Wilkins; 1995.
12. Turpeinen U, Stenman UH. Determination of urinary free cortisol by liquid chromatography-tandem mass spectrometry. Scand J Clin Lab Invest. 2003;63:143-150.
13. Taylor RL, Machacek D, Singh RJ. Validation of a high-throughput liquid chromatography-tandem mass spectrometry method for urinary cortisol and cortisone. Clin Chem. 2002;48:1511-1519.
14. Tang C, Kassahun K, McIntosh IS, et al. Simultaneous determination of urinary free cortisol and 6beta-hydroxycortisol by liquid chromatography- atmospheric pressure chemical ionization tandem mass spectrometry and its application for estimating hepatic CYP3A induction. J Chromatogr B Biomed Sci Appl. 2000;742:303-313.
15. Furuta T, Eguchi N, Shibasaki H, et al. Simultaneous determination of endogenous and 13C-labelled cortisols and cortisones in human plasma by stable isotope dilution mass spectrometry. J Chromatogr B Biomed Sci Appl. 2000;738:119-127.
16. Turpeinen U, Markkanen H, Valimaki M, et al. Determination of urinary free cortisol by HPLC. Clin Chem. 1997;43:1386-1391.
17. Gayrard V, Alvinerie M, Toutain PL. Interspecies variations of corticosteroid-binding globulin parameters. Domest Anim Endocrinol. 1996;13:35-45.
18. Hellman L, Nakada F, Zumoff B, et al. Renal capture and oxidation of cortisol in man. J Clin Endocrinol Metab. 1971;33:52-62.
19. van Uum SH, Houben AJ, Hermus AR, et al. Acute intrarenal administration of cortisol has no effect on renal blood flow in hypertensive individuals. J Hypertens. 2002;20:2275-2283.
20. Morineau G, Boudi A, Barka A, et al. Radioimmunoassay of cortisone in serum, urine, and saliva to assess the status of the cortisol-cortisone shuttle. Clin Chem. 1997;43:1397-1407.
21. Wrighton SA, Brian WR, Sari MA, et al. Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3). Mol Pharmacol. 1990;38:207-213.
22. Karssen AM, Meijer OC, van der Sandt IC, et al. Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain. Endocrinology. 2001;142:2686-2694.
23. Sirianni GL, Pang KS. Organ clearance concepts: new perspectives on old principles. J Pharmacokinet Biopharm. 1997;25:449-470.
24. Sirianni GL, Pang KS. Inhibition of esterolysis of enalapril by paraoxon increases the urinary clearance in isolated perfused rat kidney. Drug Metab Dispos. 1999;27:931-936.
25. Galteau MM, Shamsa F. Urinary 6beta-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals. Eur J Clin Pharmacol. 2003;59:713-733.
26. Lewis JG, Bagley CJ, Elder PA, et al. Plasma free cortisol fraction reflects levels of functioning corticosteroid-binding globulin. Clin Chim Acta. 2005;359:189-194.
27. Straub RH, Weidler C, Demmel B, et al. Renal clearance and daily excretion of cortisol and adrenal androgens in patients with rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis. 2004;63:961-968.
28. Furuta T, Suzuki A, Mori C, et al. Evidence for the validity of cortisol 6 beta-hydroxylation clearance as a new index for in vivo cytochrome P450 3A phenotyping in humans. Drug Metab Dispos. 2003;31:1283-1287.